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Abstract
Support structures for dermal regeneration are composed of biodegradable and bioresorbable polymers, animal skin or tendons, 
or are bacteria products. The use of such materials is controversial due to their low efficiency. An important area within tissue 
engineering is the application of multipotent mesenchymal stromal cells (MSCs) to reparative surgery. The combined use of 
biodegradable membranes with stem cell therapy may lead to promising results for patients undergoing unsuccessful conven-
tional treatments. Thus, the aim of this study was to test the efficacy of using membranes composed of anionic collagen with or 
without the addition of hyaluronic acid (HA) as a substrate for adhesion and in vitro differentiation of bone marrow-derived canine 
MSCs. The benefit of basic fibroblast growth factor (bFGF) on the differentiation of cells in culture was also tested. MSCs were 
collected from dog bone marrow, isolated and grown on collagen scaffolds with or without HA. Cell viability, proliferation rate, 
and cellular toxicity were analyzed after 7 days. The cultured cells showed uniform growth and morphological characteristics of 
undifferentiated MSCs, which demonstrated that MSCs successfully adapted to the culture conditions established by collagen 
scaffolds with or without HA. This demonstrates that such scaffolds are promising for applications to tissue regeneration. bFGF 
significantly increased the proliferative rate of MSCs by 63% when compared to groups without the addition of the growth factor. 
However, the addition of bFGF becomes limiting, since it has an inhibitory effect at high concentrations in culture medium.
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Among adult animal stem cells, those from bone marrow 
have received great attention due to their easy isolation and 
culture, high in vitro expansion potential (1-3), and ability to 
differentiate into mesenchymal (4), ectodermal (5,6), and 
endodermal (7) cells. These cells have the capacity to differ-
entiate into bone, cartilage, fat tissue, tendon, muscle (8,9), 
mature hepatocytes, epithelial cells of the skin and intestinal 
tract, and may improve heart function after myocardial infarc-
tion (10-12).
Numerous tissue engineering strategies are available today 
for the regeneration of wounded skin. The use of collagen 
membrane gels as biomaterials in plastic surgery is one of them 
and has greatly improved in recent decades. This has ultimately 
led to an increased interest in developing biodegradable and 
biocompatible materials for tissue regeneration (13-15). The 
increasing importance of collagen in the area of  biomaterials 
is due to its great abundance in the animal kingdom, the ease 
in obtaining it, and its positive physical and physicochemical 
properties for specific applications in  biomaterials.
Hyaluronic acid (HA) has a high ability to absorb water, 
which influences several cellular functions such as migra-
tion, adhesion, and cell proliferation (16,17). Furthermore, 
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HA is a major component of the extracellular matrix of mammals. 
Therefore, its application to the field of  biomaterials is promis-
ing, currently being used as bio-implants for the treatment of 
voice disorders (18), and as an injectable gel in plastic surgery 
for the management of facial aging (16,19).
Among growth factors, the fibroblast growth factor (FGF) 
family (22 family members) is of great importance in the 
process of tissue regeneration. Most members of this family 
have a wide range of mitogenic action and can stimulate the 
proliferation of cells of ectodermal, mesodermal, and endo-
dermal origin (20).
Treatment based on biomaterials is still controversial 
due to its low efficiency. However, it is believed that the 
combined use of biodegradable membranes with stem cell 
therapy may generate promising results for patients sub-
mitted to unsuccessful conventional treatments (21). Thus, 
compounds made from the combination of collagen, HA, and 
growth factors for the application of injectable biomaterials 
or in the form of membranes have been developed to attract 
cells, serving as a scaffold for tissue growth (14).
In this study, bone marrow-derived canine mesenchymal 
stromal cells (MSCs) were applied to an anionic collagen 
membrane with and without HA (22). The membrane served 
as support for adhesion and growth of the cells to develop 
a cellularized graft and to assess the effect of basic FGF 
(bFGF) on the proliferation of cultured MSCs.
 
Material and Methods
Preparation of biocomposites from native and 
anionic collagen
Anionic collagen (Coll) was developed by the Depart-
ment of Biomaterials, USP, São Carlos, SP, Brazil (22).
HA, obtained for the manufacture of membranes, was 
extracted from chicken ridges using a method developed 
by the team of Biochemistry and Biomaterials from the São 
Carlos Institute of Chemistry (USP), which is a proprietary 
process (patent pending).
For the preparation of the composites, 10:1 and 100:1 
ratios (Coll:HA) were used. After mixing, the pH of the gel 
formed was adjusted with acetic acid until the solution 
reached pH 3.5, followed by a gel degassing procedure. 
This procedure removes oxygen bubbles from the gel to 
facilitate molding.
The collagen membranes (CollM) were prepared on 24-
well microplates (Corning, USA) by coating the wells with 
300 µL solubilized collagen at 0.1% concentration (w/w) and 
left to dry at room temperature under a laminar flow hood 
for 3 days. After drying, the films were stored in a desiccator 
until use. The membranes were sterilized by immersion in 
70% ethanol, washed three times with deionized water and 
exposed to ultraviolet light overnight. 
 
Isolation and in vitro culture of multipotent MSC
MSCs were obtained by puncture of the bone marrow of 
dogs from the Veterinary Hospital (HV), School of Veterinary 
Medicine (FMVZ), UNESP, Botucatu, SP, Brazil. The animals 
were sedated with acepromazine (2% Acepran Univet, 
SP) at a dose of 0.05 mg/kg intramuscularly. After 15 min, 
general anesthesia was induced with propofol (Diprivan, 
Zeneca Farmacêutica do Brasil Ltda., Brazil) at a dose of 
6 mg/kg, intravenously. The left cephalic vein was can-
nulated to receive the 0.9% sodium chloride physiological 
solution at a dose of 20 mL.kg-1.h-1. With the dog positioned 
in left lateral decubitus, trichotomy and disinfection were 
performed with chlorhexidine in the right scapular-humeral 
joint region. Next, a needle for biopsy of the bone marrow 
was introduced into the great tuberosity of the humerus 
to reach the spinal canal. The needle was attached to a 
20-mL disposable syringe containing 1 mL sodium heparin 
(Cristália, Brazil) where, by means of a negative pressure 
gradient, 5 mL bone marrow was collected. Blood samples 
were processed at the Laboratory of Cell Therapy and 
Advanced Reproduction, Faculty of Veterinary Medicine, 
UNESP, Botucatu, SP, Brazil, and mononuclear cells were 
separated by density gradient difference using Ficoll-Paque 
(density 1077 g/mL, Amersham Biosciences, UK).
Cells were plated in 25-cm2 bottles in a high-glucose 
DMEM medium with 4 mM L-glutamine (Gibco, USA), 20% 
fetal bovine serum (Gibco), 100 IU/mL penicillin and 10 
mg/mL streptomycin (Sigma-Aldrich, USA), and 3.0 µg/mL 
amphotericin B (Sigma-Aldrich) for 14 days. The culture 
medium was replaced every 3 days.
Once the culture reached approximately 80% conflu-
ence, the cells were counted with the aid of a Neubauer 
chamber (Neubauer Improved, New Optik, Brazil), and 
transferred at a concentration of 1 x 105 cells/mL to mi-
croplates containing collagen membranes with and without 
HA (CollMHA, Coll:HA, 25:1) at 0.1% (w/w) and allowed to 
grow for 7 days.
For the control study, cells were transferred directly 
to a 24-well microplate without collagen films, which was 
maintained under the same culture conditions as the other 
groups. 
The study was divided into three parts: 1) comparison 
between CollM and CollMHA; 2) comparison between MSC 
culture on CollMHA with or without bFGF (10 and 50 ng/
mL; Sigma), and 3) determination of the effect of the ad-
dition of bFGF (10 and 50 ng/mL) on the proliferation rate 
of MSCs cultured on CollM. Data were obtained from two 
independent experiments performed in triplicate with each 
culture condition.
 
Quantitative and immunohistochemical analyses of 
MSCs
Cell viability was measured by staining cells with Hoechst 
33342 (Invitrogen, USA), which stains live cells in blue, 
and propidium iodide (Sigma-Aldrich), which stains dead 
or dying cells in red, indicating which cells are undergoing 
necrosis. For this, the culture medium of the 24-well plate 
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was removed, and 0.5 mL PBS containing 30 µL Hoechst 
33342 solution (10 mg/mL) was added to each well, and 
maintained for 40 min at 37°C. This incubation was followed 
by the addition of 10 µL propidium iodide solution (1.0 mg/
mL) and after 5 min cells were analyzed by fluorescence 
microscopy (excitation: 450 to 490 nm at 100X magnifi-
cation). The methodology was based on the analysis of 
photomicrographs of cell fields.
To measure the percentage of viable and nonviable 
cells, cells were classified according to the color of stained 
cells (blue: live; red: dead), in an area of 50 μm2. Data were 
analyzed statistically by the unpaired t-test with Welch’s 
correction, with the level of significance set at P < 0.05. Sta-
tistical analyses were performed using the GraphPad InStat 
3 statistical package (Graph Pad Software Inc., USA).
MSC viability was also assessed by Trypan blue dye 
exclusion and quantified by cell-counting in a Neubauer 
chamber. To detach cells from the membrane surface, 200 
µL 0.25% Trypsin (LGC, BR30045-01) was added to each 
well and incubated at 37°C for 5 min. For the counts in the 
Neubauer chamber, 0.4% Trypan blue (Gibco, 15250-061; 
1:1, v/v) was added. This test was conducted in triplicate.
The identities of the MSCs were confirmed by using 
CD44+ and CD34- antibodies (BD-Pharmingen, USA), 
which identify surface markers specific for MSCs. The 
standard protocol suggested by the manufacturer of each 
antibody was followed, and samples were analyzed by 
flow cytometry.
 
Results and Discussion
Cell viability analysis 
Cell viability was analyzed from photomicrographs of cell 
fields following the methods previously described. The cell 
culture after 7 days of incubation showed more confluency 
in the culture with the addition of bFGF (Figure 1A and B). 
Figure 1C and D show the viable cell nuclei stained in blue 
(Hoechst 33342) and the nonviable cell nuclei stained in 
red (propidium iodide). It is possible to visually note that the 
quantity of dead cells is small (Figure 1C and D).
Statistically, there was no significant difference in cell 
viability in the control group (91.8 ± 3.39%), on CollM (85.3 
± 9.26%) or CollMHA (85.6 ± 4.02%; P > 0.05). The high 
cell viability rates indicate that the material produced with 
or without the addition of HA to its composition does not 
exhibit in vitro cytotoxicity.
Figure 1. Photomicrographs showing MSCs in culture on CollM (A and C) and CollMHA with 10 ng/mL 
bFGF (B and D). A and B, Observation performed after 7 days of culture showing adherent MSCs after 
expansion. C and D, Live cells (blue) stained with Hoechst 33342 and cells undergoing necrosis (red) 
stained with propidium iodide. MSCs = multipotent mesenchymal stromal cells; CollM = collagen mem-
brane; CollMHA = collagen membrane plus hyaluronic acid; bFGF = basic fibroblast growth factor.
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Despite the good biocompatibility shown by both mem-
brane components, the addition of high HA concentrations 
can cause a relative disadvantage of in vitro culture since it 
reduces cell adhesion due to the negative charge of the HA 
(23). However, this potential disadvantage can be eliminated 
by modifying the surface with adhesion promoting agents 
such as laminin and poly-lysine (24). This strategy, however, 
was not needed in the present study, since the cells showed 
good adhesion regardless of treatment with HA.
Cell viability was not affected by the addition of bFGF. 
The percentage of live cells was more than 87% in all 
cultures regardless of the bFGF concentration used (data 
not shown).
Cell viability was not affected by the addition of bFGF, 
obtaining a percentage of viable cells of 95.96 ± 4.52 and 
95.75 ± 3.68 in the cultures with 10 and 50 ng/mL, respec-
tively (data not shown). 
Cell proliferation analysis 
Figure 2A shows the total number of viable cells present 
in CollM and CollMHA cultures compared to control. The 
presence of HA in the collagen matrix caused increased 
cell growth, adhesion, and proliferation, resulting in better 
culture conditions and stability. Comparison of the three 
growth conditions (control, CollM and CollMHA) showed 
a significant difference (P < 0.05); however, there was no 
significant difference between the control culture and the 
culture in CollMHA.
In vivo, collagen and HA are the predominant compo-
nents of the extracellular matrix during the early stages of 
tissue repair and, together with fibronectin, laminin, throm-
bospondin, hemonectin, and proteoglycans, they stimulate 
migration and cell proliferation, facilitate cell adhesion at 
the site of new tissue formation, and stimulate differentia-
tion into mature cell types (25). In vitro, the combination of 
collagen and HA provides a microenvironment chemically 
similar in part to the in vivo environment (17,25).
 
Effect of the addition of bFGF on the proliferation rate
The addition of 10 ng/mL bFGF to cultures of canine MSCs 
on CollMHA had a positive effect by significantly increasing the 
cell proliferation rate. An increase of up to 63% in the prolifera-
tion rate was observed in bFGF-treated cultures compared to 
cultures containing no additional growth factor (Figure 2B).
The increased cell growth has two potential explana-
tions. It was initially believed that bFGF protects the ends of 
cell chromosomes (telomeres) from the natural shortening 
that occurs at each cell division. This would provide the cells 
with an unlimited proliferative potential, as seen in germ 
cells, embryonic stem cells, or cancer cells. However, there 
is no synthesis of telomerase, an enzyme responsible for 
telomere replacement, in MSCs (26). When measuring the 
telomere length of MSCs in culture, Bianchi et al. (26) found 
that bFGF supplementation of bone marrow MSC cultures 
may promote a selective action of cells, selecting a subset 
of cells more suitable for mitotic division. 
The second specificity of bFGF was attributed by Choi 
et al. (27), who reported that bFGF binds to membrane 
tyrosine-kinase catalytic receptors, promoting the cascaded 
signaling of the ERK1/2 pathway and may also recruit 
complexes that will activate the PI3K-Akt pathway, which 
is responsible for promoting increased cell survival.
Figure 3 shows the data regarding the counting of total 
viable cells, with a comparison between the different bFGF 
concentrations (10 and 50 ng/mL) added to the culture me-
dia. The cell proliferation rate achieved by adding 10 ng/mL 
bFGF was significantly higher than that found for cultures 
with 50 ng/mL bFGF and control cultures with no bFGF (P 
< 0.05). The increase in cell proliferation in cultures with 10 
ng/mL bFGF was 26.4 and 55.7% greater compared to the 
control and 50 ng/mL bFGF cultures, respectively.
Although 50 ng/mL bFGF has also led to a significant 
increase in cell proliferation, the higher concentration re-
sulted in a decline in cell number compared to the samples 
with a lower concentration of bFGF (28).
Figure 2. Comparison of the proliferation rates of cultures (A) on collagen membranes (CollM) with and without hyaluronic 
acid (HA), and (B) on CollM plus HA (CollMHA) with and without basic fibroblast growth factor (bFGF) (10 ng/mL) com-
pared to control culture (*P < 0.05, unpaired t-test). 
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Proliferative differences could be observed between 
MSCs cultured with low and high bFGF concentrations, 
since at high concentrations, bFGF tends to stimulate cell 
differentiation. Thus, MSCs lose their multipotent charac-
teristic and hence their potential for self-renewal, reducing 
the population growth (26,28); however, cell differentiation 
analyses were not conducted in this study.
Flow cytometry analyses of MSCs 
Cell cultures on biomembranes were evaluated with 
regard to their surface antigens by staining with specific 
monoclonal antibodies. Flow cytometry analysis indicated 
that the population of cells derived from the primary culture 
showed negative reactivity for the CD34 marker, a typical 
marker for the recognition of stem cells of hematopoietic 
origin. The cells derived from the primary culture were also 
positive for CD44 (97%), a surface antigen involved in cell-
cell and cell-substrate interactions. CD44 is only expressed 
in anchorage-dependent cells, indicating that these cells 
belong to the bone marrow-derived mesenchymal cell 
lineage, as illustrated in Figure 4.
On the basis of these experiments, we conclude that 
collagen-based membranes showed a high degree of 
tissue compatibility and can be considered to be an ex-
cellent substrate for adhesion and proliferation of canine 
MSCs. These properties can be used in clinical practice 
for the regeneration of damaged tissues. Proliferation 
was more intense in the presence of the growth factor 
bFGF, confirming the efficacy of this factor for stimulat-
ing cell growth.
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